Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine

Anticancer Drugs. 2002 Aug;13(7):777-80. doi: 10.1097/00001813-200208000-00013.

Abstract

Venlafaxine is an antidepressant which acts through the inhibition of the reuptake of norepinephrine and serotonin. Venlafaxine is active against neuropathic and chronic pain. We report the case of a 69-year-old woman who presented a paclitaxel-induced neuropathy. She presented paresthesias, pin pricks in both hands with functional impairment. Venlafaxine hydrochloride was introduced at 37.5 mg twice daily. The patient noticed a dramatic recovery of her symptoms within 2 days, with both reduction of the paresthesias and functional improvement. This is the first report of efficacious use of venlafaxine for the treatment of paclitaxel cumulative neurosensory toxicity.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / complications
  • Adenocarcinoma / drug therapy
  • Aged
  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Cyclohexanols / therapeutic use*
  • Female
  • Humans
  • Neurotoxicity Syndromes / drug therapy*
  • Ovarian Neoplasms / complications
  • Ovarian Neoplasms / drug therapy
  • Paclitaxel / adverse effects*
  • Paresthesia / chemically induced
  • Paresthesia / drug therapy
  • Sensation Disorders / chemically induced
  • Sensation Disorders / drug therapy*
  • Venlafaxine Hydrochloride

Substances

  • Antidepressive Agents, Second-Generation
  • Antineoplastic Agents, Phytogenic
  • Cyclohexanols
  • Venlafaxine Hydrochloride
  • Paclitaxel